Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

著者: Géraldine Gebhart, Laetitia E. Lamberts, Zéna Wimana, Camilo Garcia, Patrick Emonts, Lieveke Ameye, Sigrid Stroobants, Manon Huizing, P. Aftimos, J. Tol, Wim J.G. Oyen, Daniëlle J. Vugts, Otto S. Hoekstra, Carolina P. Schröder, C. Willemien Menke‐van der Houven van Oordt, Thomas Guiot, Adrienne H. Brouwers, Ahmad Awada, Elisabeth G.E. de Vries, P. Flamen - Annals of Oncology 2015 被引用: 348